The US Food and Drug Administration has down-classified cardiovascular software used to analyze heart vitals. The move is the latest from the agency in down-classifying digital health software that could help more sponsors submit premarket applications and increase market competition.
The FDA published on 14 February a final order stating adjunctive predictive cardiovascular indicator software are now class II...